ArticleJournal of cancer research and clinical oncology2025
RAF1 promotes anlotinib resistance in non-small cell lung cancer by inhibiting apoptosis.
Shuo Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it